AI assistant
Sending…
Precipio, Inc. — Director's Dealing 2013
May 7, 2013
34807_dirs_2013-05-07_1972e331-7d8a-4434-b8dc-ac29df0de259.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: TRANSGENOMIC INC (TBIO.OB)
CIK: 0001043961
Period of Report: 2013-05-03
Reporting Person: Tuttle Craig James (Director, President and CEO)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2013-05-03 | Purchase Option | $0.35 | A | 83334 | Acquired | 2023-05-02 | Common Stock (83334) | Direct |
| 2013-05-03 | Purchase Option | $0.35 | A | 83333 | Acquired | 2023-05-02 | Common Stock (83333) | Direct |
| 2013-05-03 | Purchase Option | $0.35 | A | 83333 | Acquired | 2023-05-02 | Common Stock (83333) | Direct |
Footnotes
F1: Common Stock, par value $.01 per share of Transgenomic, Inc.
F2: The various numbers listed in Columns 5, 7 and 9 relate to a single option grant which entitles the reporting person to purchase up to an aggregate of 250,000 shares of Common Stock, par value $.01 per share of Transgenomic, Inc.
More from Precipio, Inc.
Interim / Quarterly Report
2026
May 14
Regulatory Filings
2026
May 6
Earnings Release
2026
Feb 27
Major Shareholding Notification
2026
Feb 10
Regulatory Filings
2026
Jan 26
Director's Dealing
2026
Jan 20
Director's Dealing
2026
Jan 20
Director's Dealing
2026
Jan 20
Director's Dealing
2026
Jan 20
Director's Dealing
2026
Jan 20